Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| NYSE | USD | Real-time | ||
| Mexico | MXN | Delayed | ||
| Stockholm | SEK | Real-time | ||
| Frankfurt | EUR | Delayed | ||
| TradeGate | EUR | Delayed | ||
| Hamburg | EUR | Delayed | ||
| Xetra | EUR | Delayed | ||
| Santiago | USD | Delayed | ||
| Buenos Aires | ARS | Delayed | ||
| BM&FBovespa | BRL | Delayed | ||
| Vienna | EUR | Delayed | ||
| KASE | USD | Delayed | ||
| Colombia | COP | Delayed | ||
| Lima | USD | Delayed |
By Bernard Orr and Martin Quin Pollard BEIJING (Reuters) - The number of COVID patients needing critical care in China's hospitals has peaked, health authorities said on Thursday,...
JERUSALEM (Reuters) - Israel has not identified any evidence linking strokes to an updated coronavirus vaccine made by U.S. drugmaker Pfizer (NYSE:PFE) and its German partner...
By Sophie Yu and Martin Quin Pollard BEIJING (Reuters) -When Li's 83-year-old father with diabetes started coughing and complaining of body aches last month, the Beijing resident...
Drugmaker Merck's (NYSE:MRK) stock has outperformed its competitors year to date (ytd), rising 30.6%. Pfizer (NYSE:PFE), which I am bearish on, is down 16.9% so far this year. The...
Pfizer (NYSE:PFE) faces a $16 to $18 billion loss in revenue from 2025 through 2030 as it loses essential patents on five drugs.The drugs account for 40% of the company's Q3...
It remains difficult to bet against J&J in the long term Near-term challenges around currency and inflation will linger into 2023 Investors probably shouldn’t rush to...
Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operations through two segments: Biopharma and PC1. Biopharma is a science-based medicines business that includes six therapeutic areas, such as Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation & Immunology. PC1 is its global contract development and manufacturing organization and supplier of specialty active pharmaceutical ingredients. Its Vaccines include Comirnaty/BNT162b2, the Prevnar family, Nimenrix and others. Its Oncology products include Ibrance, Xtandi, Inlyta, Sutent, Retacrit, Lorbrena and Braftovi. Its Internal Medicine products include Eliquis and the Premarin family. Its Inflammation & Immunology products include Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis and Cibinqo. It also offers Rimegepant and Zavegepant.
| Average | 53.97 (+19.64% Upside) |
| High | 75.00 |
| Low | 44.00 |
| Price | 45.11 |
| No. of Analysts | 24 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Buy | Sell | Strong Sell | Neutral |
| Technical Indicators | Buy | Strong Buy | Buy | Strong Sell | Sell |
| Summary | Strong Buy | Strong Buy | Neutral | Strong Sell | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 137.87 | 138.02 | 134.22 | +2.60 | +1.92% | 79.38M | NASDAQ | |||
| 98.02 | 98.30 | 95.02 | +4.97 | +5.34% | 62.67M | NASDAQ | |||
| 97.25 | 97.35 | 93.20 | +3.57 | +3.81% | 66.76M | NASDAQ | |||
| 19.23 | 19.23 | 18.77 | +0.29 | +1.53% | 37.78M | NYSE | |||
| 178.39 | 178.56 | 168.25 | +10.74 | +6.41% | 56.05M | NASDAQ | |||
| 240.22 | 240.74 | 234.51 | +8.29 | +3.57% | 34.98M | NASDAQ | |||
| 33.85 | 33.89 | 33.08 | +0.62 | +1.87% | 44.26M | NYSE | |||
| 11.07 | 11.34 | 10.83 | +0.30 | +2.79% | 38.73M | NYSE | |||
| 126.62 | 126.64 | 124.04 | +2.09 | +1.68% | 5.52M | NYSE | |||
| 122.90 | 122.96 | 117.34 | +5.32 | +4.52% | 8.81M | NASDAQ | |||
| 3.35 | 3.76 | 3.31 | -0.44 | -11.61% | 51.89M | NASDAQ | |||
| 142.97 | 143.15 | 140.15 | +0.55 | +0.39% | 8.57M | NYSE | |||
| 105.04 | 105.20 | 103.89 | +0.78 | +0.75% | 6.46M | NASDAQ | |||
| 5.68 | 5.74 | 5.50 | -0.25 | -4.22% | 26.34M | NASDAQ | |||
| 249.71 | 249.92 | 244.76 | +3.96 | +1.61% | 2.93M | NYSE |